David P. Southwell, Director at PTC THERAPEUTICS, INC. (PTCT), sold 19,900 shares at $44.71 ($897K) on 2023-03-27, disclosed to the SEC on 2023-03-29.
Scheduled sale ($897k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.71 | 4,599 | $206K | 22.9% |
| 2 | $44.71 | 4,599 | $206K | 22.9% |
| 3 | $45.41 | 5,301 | $241K | 26.8% |
| 4 | $45.41 | 5,301 | $241K | 26.8% |
| 5 | $46.03 | 100 | $5K | 0.5% |
| Total | $45.09 avg | 19,900 |
| $897K |
| 100% |
| Filing → |
| PTCT | SELL | 2023-04-19 | $1.2M | — | Filing → |
| PTCT | SELL | 2023-04-04 | $257K | — | Filing → |
| TCRX | BUY | 2022-05-20 | $90K | — | Filing → |